TRVI icon

Trevi Therapeutics
TRVI

Upgrade to unlock
Buy
Hold
Sell

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$19.8
49% upside
High target

5 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Leerink Partners
Leerink Partners
Faisal Khurshid
100% 1-yr TRVI win rate
20 Nov ‘25 7 days ago
D. Boral Capital
D. Boral Capital
Jason Kolbert
60% 1-yr TRVI win rate
14 Nov ‘25 13 days ago
Oppenheimer
Oppenheimer
Leland Gershell
100% 1-yr TRVI win rate
14 Nov ‘25 13 days ago
Morgan Stanley
Morgan Stanley
Judah Frommer
100% 1-yr TRVI win rate
14 Nov ‘25 13 days ago
Clear Street
Clear Street
Kaveri Pohlman
100% 1-yr TRVI win rate
14 Nov ‘25 13 days ago